Thiol-based redox proteomics in cancer research

Proteomics

Volumn 15, Issue 2-3, 2015, Pages 287-299

  Yuan, Kefei ^a   Liu, Yuan ^a   Chen, Hai Ning ^a   Zhang, Lu ^a   Lan, Jiang ^a   Gao, Wei ^a   Dou, Qianhui ^a   Nice, Edouard C ^a,b   Huang, Canhua ^a  

^a SICHUAN UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Biomedicine; Cancer biomarkers; Comparative proteomics; Mass spectrometry; Qxidative stress; Signal transduction

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; ATM PROTEIN; COFILIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; FAS ANTIGEN; GLUTATHIONE PEROXIDASE; HIGH MOBILITY GROUP B1 PROTEIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPOCORTIN 2; PROTEIN KINASE LYN; PYRUVATE KINASE; PYRUVATE KINASE M2; SUMO 3 PROTEIN; THIOL; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; PROTEIN; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

CANCER RESEARCH; CELL DEATH; HIGH THROUGHPUT SCREENING; HUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEOMICS; REGULATORY MECHANISM; REVIEW; ANIMAL; MASS SPECTROMETRY; METABOLISM; NEOPLASM; OXIDATIVE STRESS; PROCEDURES;

ANIMALS; HUMANS; MASS SPECTROMETRY; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; PROTEOMICS; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS;

EID: 84921372345     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400164     Document Type: Review

References (132)

1. Bray, F., Jemal, A., Grey, N., Ferlay, J. et al., Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012, 13, 790-801.
2. Siegel, R., Ma, J., Zou, Z., Jemal, A., Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64, 9-29.
3. Stamler, J. S., Lamas, S., Fang, F. C., Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001, 106, 675-683.
4. Bogdan, C., Rollinghoff, M., Diefenbach, A., The role of nitric oxide in innate immunity. Immunol. Rev. 2000, 173, 17-26.
5. Li, H., Forstermann, U., Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 2000, 190, 244-254.
6. Petros, A., Lamb, G., Leone, A., Moncada, S. et al., Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 1994, 28, 34-39.
7. Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K. et al., Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 1996, 93, 2448-2453.
8. Adler, H., Beland, J. L., Del-Pan, N. C., Kobzik, L. et al., Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J. Exp. Med. 1997, 185, 1533-1540.
9. Gao, X. P., Standiford, T. J., Rahman, A., Newstead, M. et al., Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice. J. Immunol. 2002, 168, 3974-3982.
10. Morgenstern, D. E., Gifford, M. A., Li, L. L., Doerschuk, C. M. et al., Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 1997, 185, 207-218.
11. Trachootham, D., Alexandre, J., Huang, P., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 2009, 8, 579-591.
12. Gorrini, C., Harris, I. S., Mak, T. W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 2013, 12, 931-947.
13. Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y. et al., Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006, 10, 241-252.
14. Shibutani, S., Takeshita, M., Grollman, A. P., Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991, 349, 431-434.
15. Antelmann, H., Helmann, J. D., Thiol-based redox switches and gene regulation. Antioxid. Redox Signal. 2011, 14, 1049-1063.
16. Butterfield, D. A., Dalle-Donne, I., Redox proteomics: from protein modifications to cellular dysfunction and disease. Mass Spectrom. Rev. 2014, 33, 1-6.
17. Raftery, M. J., Determination of oxidative protein modifications using mass spectrometry. Redox Rep. 2014, 19, 140-147.
18. Di Domenico, F., Pupo, G., Tramutola, A., Giorgi, A. et al., Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease. Free Radic. Biol. Med. 2014, 71, 270-280.
19. Perluigi, M., Swomley, A. M., Butterfield, D. A., Redox proteomics and the dynamic molecular landscape of the aging brain. Ageing Res. Rev. 2014, 13, 75-89.
20. Perluigi, M., Di Domenico, F., Buttterfield, D. A., Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics. Proteomics Clin. Appl. 2014, 8, 73-85.
21. Zhao, Y., Miriyala, S., Miao, L., Mitov, M. et al., Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radic. Biol. Med. 2014, 72, 55-65.
22. Braconi, D., Millucci, L., Ghezzi, L., Santucci, A., Redox proteomics gives insights into the role of oxidative stress in alkaptonuria. Expert Rev. Proteomics 2013, 10, 521-535.
23. Basu, A., Saha, S., Karmakar, S., Chakravarty, S. et al., 2D DIGE based proteomics study of erythrocyte cytosol in sickle cell disease: altered proteostasis and oxidative stress. Proteomics 2013, 13, 3233-3242.
24. Di Domenico, F., Sultana, R., Ferree, A., Smith, K. et al., Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease. Antioxid. Redox Signal. 2012, 17, 1490-1506.
25. Bachi, A., Dalle-Donne, I., Scaloni, A., Redox proteomics: chemical principles, methodological approaches and biological/biomedical promises. Chem. Rev. 2013, 113, 596-698.
26. Hogg, P. J., Targeting allosteric disulphide bonds in cancer. Nat. Rev. Cancer 2013, 13, 425-431.
27. Unwin, R. D., Griffiths, J. R., Whetton, A. D., Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS. Nat. Protoc. 2010, 5, 1574-1582.
28. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J. et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633-641.
29. Whiteaker, J. R., Zhao, L., Anderson, L., Paulovich, A. G., An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics 2010, 9, 184-196.
30. Leichert, L. I., Jakob, U., Protein thiol modifications visualized in vivo. PLoS Biol. 2004, 2, e333.
31. Leichert, L. I., Gehrke, F., Gudiseva, H. V., Blackwell, T. et al., Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc. Natl. Acad. Sci. USA 2008, 105, 8197-8202.
32. Bellew, M., Coram, M., Fitzgibbon, M., Igra, M. et al., A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics 2006, 22, 1902-1909.
33. Thompson, A., Schafer, J., Kuhn, K., Kienle, S. et al., Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 2003, 75, 1895-1904.
34. Dayon, L., Pasquarello, C., Hoogland, C., Sanchez, J. C. et al., Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags. J. Proteomics 2010, 73, 769-777.
35. Uehara, T., Nakamura, T., Yao, D., Shi, Z. Q. et al., S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441, 513-517.
36. Murray, C. I., Uhrigshardt, H., O'Meally, R. N., Cole, R. N. et al., Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol. Cell. Proteomics 2012, 11, M111 013441.
37. Weerapana, E., Wang, C., Simon, G. M., Richter, F. et al., Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 2010, 468, 790-795.
38. Deng, X., Weerapana, E., Ulanovskaya, O., Sun, F. et al., Proteome-wide quantification and characterization of oxidation-sensitive cysteines in pathogenic bacteria. Cell Host Microbe 2013, 13, 358-370.
39. Rostovtsev, V. V., Green, L. G., Fokin, V. V., Sharpless, K. B., A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem. Int. Ed. Engl. 2002, 41, 2596-2599.
40. Tornoe, C. W., Christensen, C., Meldal, M., Peptidotriazoles on solid phase: [1, 2, 3]-triazoles by regiospecific copper(i)-catalyzed 1, 3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057-3064.
41. Tabb, D. L., McDonald, W. H., Yates, J. R., 3rd, DTASelect and Contrast:tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 2002, 1, 21-26.
42. Klomsiri, C., Nelson, K. J., Bechtold, E., Soito, L. et al., Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteins. Methods Enzymol. 2010, 473, 77-94.
43. Seo, Y. H., Carroll, K. S., Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies. Proc. Natl. Acad. Sci. USA 2009, 106, 16163-16168.
44. Karisch, R., Fernandez, M., Taylor, P., Virtanen, C. et al., Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome". Cell 2011, 146, 826-840.
45. Rhee, S. G., Bae, Y. S., Lee, S. R., Kwon, J., Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000, 2000, pe1.
46. Salmeen, A., Andersen, J. N., Myers, M. P., Meng, T. C. et al., Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003, 423, 769-773.
47. van Montfort, R. L., Congreve, M., Tisi, D., Carr, R. et al., Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 2003, 423, 773-777.
48. Chen, C. Y., Willard, D., Rudolph, J., Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines. Biochemistry 2009, 48, 1399-1409.
49. Tonks, N. K., Redox redux: revisiting PTPs and the control of cell signaling. Cell 2005, 121, 667-670.
50. Persson, C., Kappert, K., Engstrom, U., Ostman, A. et al., An antibody-based method for monitoring in vivo oxidation of protein tyrosine phosphatases. Methods 2005, 35, 37-43.
51. Groen, A., Lemeer, S., van der Wijk, T., Overvoorde, J. et al., Differential oxidation of protein-tyrosine phosphatases. J. Biol. Chem. 2005, 280, 10298-10304.
52. Persson, C., Sjoblom, T., Groen, A., Kappert, K. et al., Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 2004, 101, 1886-1891.
53. Weibrecht, I., Bohmer, S. A., Dagnell, M., Kappert, K. et al., Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2. Free Radic. Biol. Med. 2007, 43, 100-110.
54. Huyer, G., Liu, S., Kelly, J., Moffat, J. et al., Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 1997, 272, 843-851.
55. Gstaiger, M., Aebersold, R., Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat. Rev. Genet. 2009, 10, 617-627.
56. Walther, T. C., Mann, M., Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 2010, 190, 491-500.
57. Yates, J. R., Ruse, C. I., Nakorchevsky, A., Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 2009, 11, 49-79.
58. Elschenbroich, S., Kislinger, T., Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol. Biosyst. 2011, 7, 292-303.
59. Schouten, S., Huguet, C., Hopmans, E. C., Kienhuis, M. V. et al., Analytical methodology for TEX86 paleothermometry by high-performance liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry. Anal. Chem. 2007, 79, 2940-2944.
60. Dalle-Donne, I., Scaloni, A., Giustarini, D., Cavarra, E. et al., Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom. Rev. 2005, 24, 55-99.
61. Yeh, J. I., Claiborne, A., Hol, W. G., Structure of the native cysteine-sulfenic acid redox center of enterococcal NADH peroxidase refined at 2.8 A resolution. Biochemistry 1996, 35, 9951-9957.
62. Reddie, K. G., Carroll, K. S., Expanding the functional diversity of proteins through cysteine oxidation. Curr. Opin. Chem. Biol. 2008, 12, 746-754.
63. Paulsen, C. E., Carroll, K. S., Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem. Biol. 2010, 5, 47-62.
64. Klomsiri, C., Karplus, P. A., Poole, L. B., Cysteine-based redox switches in enzymes. Antioxid. Redox Signal. 2011, 14, 1065-1077.
65. Johnson, G. L., Lapadat, R., Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1912.
66. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P. et al., Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275, 90-94.
67. Gotoh, Y., Cooper, J. A., Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J. Biol. Chem. 1998, 273, 17477-17482.
68. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K. et al., Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998, 17, 2596-2606.
69. Ray, P. D., Huang, B. W., Tsuji, Y., Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24, 981-990.
70. Heidary Arash, E., Attisano, L., A role for Hipk in the Hippo pathway. Sci. Signal. 2013, 6, pe18.
71. Puca, R., Nardinocchi, L., Givol, D., D'Orazi, G., Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene 2010, 29, 4378-4387.
72. Rinaldo, C., Siepi, F., Prodosmo, A., Soddu, S., HIPKs: Jack of all trades in basic nuclear activities. Biochim. Biophys. Acta 2008, 1783, 2124-2129.
73. de la Vega, L., Grishina, I., Moreno, R., Kruger, M. et al., A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol. Cell 2012, 46, 472-483.
74. Peter, M. E., Budd, R. C., Desbarats, J., Hedrick, S. M. et al., The CD95 receptor: apoptosis revisited. Cell 2007, 129, 447-450.
75. Wajant, H., The Fas signaling pathway: more than a paradigm. Science 2002, 296, 1635-1636.
76. Anathy, V., Aesif, S. W., Guala, A. S., Havermans, M. et al., Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. J. Cell Biol. 2009, 184, 241-252.
77. Croker, B. A., O'Donnell, J. A., Nowell, C. J., Metcalf, D. et al., Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proc. Natl. Acad. Sci. USA 2011, 108, 13135-13140.
78. Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J. et al., Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 2012, 209, 1519-1528.
79. Tang, D., Kang, R., Cheh, C. W., Livesey, K. M. et al., HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29, 5299-5310.
80. Bianchi, M. E., DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81, 1-5.
81. Yang, H., Lundback, P., Ottosson, L., Erlandsson-Harris, H. et al., Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 2012, 18, 250-259.
82. Chua, B. T., Volbracht, C., Tan, K. O., Li, R. et al., Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat. Cell Biol. 2003, 5, 1083-1089.
83. Zhu, B., Fukada, K., Zhu, H., Kyprianou, N., Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells. Cancer Res. 2006, 66, 8640-8647.
84. Mannherz, H. G., Gonsior, S. M., Gremm, D., Wu, X. et al., Activated cofilin colocalises with Arp2/3 complex in apoptotic blebs during programmed cell death. Eur. J. Cell Biol. 2005, 84, 503-515.
85. Fratelli, M., Demol, H., Puype, M., Casagrande, S. et al., Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc. Natl. Acad. Sci. USA 2002, 99, 3505-3510.
86. Klamt, F., Zdanov, S., Levine, R. L., Pariser, A. et al., Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat. Cell Biol. 2009, 11, 1241-1246.
87. Vander Heiden, M. G., Cantley, L. C., Thompson, C. B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324, 1029-1033.
88. Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A. et al., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452, 230-233.
89. David, C. J., Chen, M., Assanah, M., Canoll, P. et al., HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463, 364-368.
90. Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B. et al., Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334, 1278-1283.
91. Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. et al., Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452, 181-186.
92. Butterfield, D. A., Poon, H. F., St Clair, D., Keller, J. N. et al., Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol. Dis. 2006, 22, 223-232.
93. Munzel, T., Feil, R., Mulsch, A., Lohmann, S. M. et al., Physiology and pathophysiology of vascular signaling controlled by guanosine 3', 5'-cyclic monophosphate-dependent protein kinase [corrected]. Circulation 2003, 108, 2172-2183.
94. Kwon, I. K., Schoenlein, P. V., Delk, J., Liu, K. et al., Expression of cyclic guanosine monophosphate-dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis. Cancer 2008, 112, 1462-1470.
95. Burgoyne, J. R., Madhani, M., Cuello, F., Charles, R. L. et al., Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317, 1393-1397.
96. Shackelford, D. B., Shaw, R. J., The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 2009, 9, 563-575.
97. Motoshima, H., Goldstein, B. J., Igata, M., Araki, E., AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 2006, 574, 63-71.
98. Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A. et al., Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 2010, 285, 33154-33164.
99. Shao, D., Oka, S., Liu, T., Zhai, P. et al., A redox-dependent mechanism for regulation of AMPK activation by thioredoxin1 during energy starvation. Cell Metab. 2014, 19, 232-245.
100. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y. et al., Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 2000, 97, 10389-10394.
101. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y. et al., Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998, 281, 1677-1679.
102. Falck, J., Mailand, N., Syljuasen, R. G., Bartek, J. et al., The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410, 842-847.
103. Burma, S., Chen, B. P., Murphy, M., Kurimasa, A. et al., ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276, 42462-42467.
104. Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D. et al., ATM activation by oxidative stress. Science 2010, 330, 517-521.
105. Scapini, P., Pereira, S., Zhang, H., Lowell, C. A., Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol. Rev. 2009, 228, 23-40.
106. Nathan, C., Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 2006, 6, 173-182.
107. Dvorak, H. F., Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 1986, 315, 1650-1659.
108. Klyubin, I. V., Kirpichnikova, K. M., Gamaley, I. A., Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils. Eur. J. Cell Biol. 1996, 70, 347-351.
109. Feng, Y., Santoriello, C., Mione, M., Hurlstone, A. et al., Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol. 2010, 8, e1000562.
110. Moreira, S., Stramer, B., Evans, I., Wood, W. et al., Prioritization of competing damage and developmental signals by migrating macrophages in the Drosophila embryo. Curr. Biol. 2010, 20, 464-470.
111. Niethammer, P., Grabher, C., Look, A. T., Mitchison, T. J., A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009, 459, 996-999.
112. Yoo, S. K., Starnes, T. W., Deng, Q., Huttenlocher, A., Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 2011, 480, 109-112.
113. Utomo, A., Jiang, X., Furuta, S., Yun, J. et al., Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. J. Biol. Chem. 2004, 279, 43522-43529.
114. Kumar, B., Koul, S., Khandrika, L., Meacham, R. B. et al., Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008, 68, 1777-1785.
115. Lubos, E., Loscalzo, J., Handy, D. E., Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2011, 15, 1957-1997.
116. Wei, P. C., Hsieh, Y. H., Su, M. I., Jiang, X. et al., Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and induces systemic disease. Mol. Cell 2012, 48, 747-759.
117. Gao, P., Zhang, H., Dinavahi, R., Li, F. et al., HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 2007, 12, 230-238.
118. Xia, C., Meng, Q., Liu, L. Z., Rojanasakul, Y. et al., Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007, 67, 10823-10830.
119. Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S. et al., Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol. Cell. Biol. 2008, 28, 718-731.
120. Huang, C., Han, Y., Wang, Y., Sun, X. et al., SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 2009, 28, 2748-2762.
121. Yan, S., Sun, X., Xiang, B., Cang, H. et al., Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J. 2010, 29, 3773-3786.
122. Olsson, A. K., Dimberg, A., Kreuger, J., Claesson-Welsh, L., VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7, 359-371.
123. Kang, D. H., Lee, D. J., Lee, K. W., Park, Y. S. et al., Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol. Cell 2011, 44, 545-558.
124. Fu, Z., Tindall, D. J., FOXOs, cancer and regulation of apoptosis. Oncogene 2008, 27, 2312-2319.
125. Accili, D., Arden, K. C., FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117, 421-426.
126. Rached, M. T., Kode, A., Xu, L., Yoshikawa, Y. et al., FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010, 11, 147-160.
127. Dansen, T. B., Smits, L. M., van Triest, M. H., de Keizer, P. L. et al., Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 2009, 5, 664-672.
128. Lokman, N. A., Ween, M. P., Oehler, M. K., Ricciardelli, C., The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 2011, 4, 199-208.
129. Madureira, P. A., Hill, R., Miller, V. A., Giacomantonio, C. et al., Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget 2011, 2, 1075-1093.
130. Madureira, P. A., Waisman, D. M., Annexin A2: the importance of being redox sensitive. Int. J. Mol. Sci. 2013, 14, 3568-3594.
131. Poole, L. B., Karplus, P. A., Claiborne, A., Protein sulfenic acids in redox signaling. Annu. Rev. Pharmacol. Toxicol. 2004, 44, 325-347.
132. Hochgrafe, F., Mostertz, J., Albrecht, D., Hecker, M., Fluorescence thiol modification assay: oxidatively modified proteins in Bacillus subtilis. Mol. Microbiol. 2005, 58, 409-425.